195 related articles for article (PubMed ID: 15528268)
1. Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
Jorgensen R; Martini L; Schwartz TW; Elling CE
Mol Endocrinol; 2005 Mar; 19(3):812-23. PubMed ID: 15528268
[TBL] [Abstract][Full Text] [Related]
2. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
3. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle.
Penn RB; Pascual RM; Kim YM; Mundell SJ; Krymskaya VP; Panettieri RA; Benovic JL
J Biol Chem; 2001 Aug; 276(35):32648-56. PubMed ID: 11418617
[TBL] [Abstract][Full Text] [Related]
4. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization.
Bisello A; Manen D; Pierroz DD; Usdin TB; Rizzoli R; Ferrari SL
Mol Endocrinol; 2004 Jun; 18(6):1486-98. PubMed ID: 14988434
[TBL] [Abstract][Full Text] [Related]
5. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein.
Vilardaga JP; Frank M; Krasel C; Dees C; Nissenson RA; Lohse MJ
J Biol Chem; 2001 Sep; 276(36):33435-43. PubMed ID: 11387315
[TBL] [Abstract][Full Text] [Related]
6. Development of a BRET2 screening assay using beta-arrestin 2 mutants.
Vrecl M; Jorgensen R; Pogacnik A; Heding A
J Biomol Screen; 2004 Jun; 9(4):322-33. PubMed ID: 15191649
[TBL] [Abstract][Full Text] [Related]
7. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
Huet E; Boulay F; Barral S; Rabiet MJ
Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
[TBL] [Abstract][Full Text] [Related]
8. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization.
Ouedraogo M; Lecat S; Rochdi MD; Hachet-Haas M; Matthes H; Gicquiaux H; Verrier S; Gaire M; Glasser N; Mély Y; Takeda K; Bouvier M; Galzi JL; Bucher B
Traffic; 2008 Mar; 9(3):305-24. PubMed ID: 18088318
[TBL] [Abstract][Full Text] [Related]
9. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
10. Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).
Jorgensen R; Kubale V; Vrecl M; Schwartz TW; Elling CE
J Pharmacol Exp Ther; 2007 Jul; 322(1):148-54. PubMed ID: 17395766
[TBL] [Abstract][Full Text] [Related]
11. NK1 receptor fused to beta-arrestin displays a single-component, high-affinity molecular phenotype.
Martini L; Hastrup H; Holst B; Fraile-Ramos A; Marsh M; Schwartz TW
Mol Pharmacol; 2002 Jul; 62(1):30-7. PubMed ID: 12065752
[TBL] [Abstract][Full Text] [Related]
12. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
[TBL] [Abstract][Full Text] [Related]
13. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3',5'-monophosphate signaling by beta-arrestin2.
Ferrari SL; Bisello A
Mol Endocrinol; 2001 Jan; 15(1):149-63. PubMed ID: 11145746
[TBL] [Abstract][Full Text] [Related]
14. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins.
Key TA; Vines CM; Wagener BM; Gurevich VV; Sklar LA; Prossnitz ER
Traffic; 2005 Feb; 6(2):87-99. PubMed ID: 15634210
[TBL] [Abstract][Full Text] [Related]
17. A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.
Lan H; Liu Y; Bell MI; Gurevich VV; Neve KA
Mol Pharmacol; 2009 Jan; 75(1):113-23. PubMed ID: 18809670
[TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin2 as a competitor for GRK2 interaction with the GLP-1 receptor upon receptor activation.
Jorgensen R; Norklit Roed S; Heding A; Elling CE
Pharmacology; 2011; 88(3-4):174-81. PubMed ID: 21952200
[TBL] [Abstract][Full Text] [Related]
19. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT(2A) receptor induces agonist-independent internalization.
Gray JA; Bhatnagar A; Gurevich VV; Roth BL
Mol Pharmacol; 2003 May; 63(5):961-72. PubMed ID: 12695524
[TBL] [Abstract][Full Text] [Related]
20. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling.
Chen W; Kirkbride KC; How T; Nelson CD; Mo J; Frederick JP; Wang XF; Lefkowitz RJ; Blobe GC
Science; 2003 Sep; 301(5638):1394-7. PubMed ID: 12958365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
